Highest-materiality recent filing
Welltower enters $7.5B ATM equity distribution agreement; also registers 261,753 resale shares
Entered new equity distribution agreement for up to $7.5B of common stock sales through multiple agents and forward sellers.
Welltower Q2 normalized FFO $1.60, up 25% YoY; raises dividend 15% to $0.85
Net income $0.61/diluted share; normalized FFO $1.60/diluted share, up 25% YoY.
Welltower raises quarterly dividend 15% to $0.85/share; strong cash flow and pipeline cited
New quarterly dividend of $0.85 per share, a ~15% increase, beginning Q2 2026 (subject to Board approval).
Welltower Q1 normalized FFO $1.47 (+23% YoY), closes C$4.1B Amica acquisition, raises guidance
Net income of $1.02 per diluted share; normalized FFO of $1.47 per diluted share, up 23% YoY.
Welltower Q4 normalized FFO $1.45 (+28.3% YoY); guides 2026 FFO $6.09-$6.25
Q4 normalized FFO $1.45/diluted share (+28.3% YoY); net income $0.14/diluted share.
Welltower enters new $7.5B ATM equity distribution agreement; registers resale and OP shares
New ATM agreement allows sale of up to $7.5B in common stock through 27 sales agents and forward sellers; prior March 2025 agreement terminated.
Welltower Q3 normalized FFO $1.34 (+20.7%); $23B deals including £5.2B Barchester
Q3 normalized FFO $1.34 per diluted share (+20.7% YoY); net income $0.41; SSNOI +14.5% with SHO +20.3%.
Welltower Q2 normalized FFO $1.28/share, up 21.9% YoY; raises full-year guidance
Reported net income $0.45 diluted EPS; normalized FFO $1.28/share (+21.9% YoY).
Welltower Q1 normalized FFO $1.20/share, +18.8% YoY; raises FY 2025 guidance
Net income $0.40/diluted share; normalized FFO $1.20/diluted share, up 18.8% YoY.
Welltower establishes new $7.5B ATM equity program, terminates prior facility
New ATM program allows sale of up to $7.5B in common stock through multiple agents and forward sellers.
Welltower Q4 normalized FFO $1.13 (+17.7%); raises dividend 10%; 2025 FFO guide $4.79-$4.95
Q4 normalized FFO $1.13/sh vs $0.96 prior year (+17.7%); net income $0.19/sh.
Welltower enters $5B ATM equity distribution agreement, terminates prior program
New equity distribution agreement allows sales of up to $5B in common stock through sales agents or forward sellers.
Welltower Q3 net income $0.73/sh, normalized FFO $1.11/sh (+20.7% YoY), raises 2024 guidance
Net income $0.73 diluted EPS; normalized FFO $1.11 diluted EPS (up 20.7% YoY).
Welltower Q2 normalized FFO $1.05, up 16.7% YoY; dividend raised 10% to $0.67
Net income $0.42 diluted EPS; normalized FFO $1.05, up 16.7% YoY (19.3% excl. subsidies).
Welltower enters $3.5B equity distribution agreement for common stock ATM program
New equity distribution agreement with multiple sales agents and forward purchasers for up to $3.5B of common stock.
Welltower Q1 normalized FFO $1.01, up 18.8% YoY; raises 2024 guidance
Net income $0.22/diluted share; normalized FFO $1.01/diluted share, up 18.8% YoY.
Welltower Q4 normalized FFO $0.96 (+15.7% YoY); 2024 guidance $3.94-$4.10
Q4 net income $0.15/diluted share; normalized FFO $0.96, up 15.7% YoY.
Welltower closes public offering of 17.5M shares of common stock
Issued 17,500,000 shares of common stock under automatic shelf registration.
Welltower Q3 normalized FFO $0.92; total same-store NOI +14.1%; lifts FY23 guidance
Q3 net income $0.24/diluted share; normalized FFO $0.92/diluted share.
Welltower enters new $4B ATM equity distribution program, terminates prior facility
New equity distribution agreement allows up to $4B in common stock sales through multiple agents and forward sellers.
Welltower Q2 normalized FFO $0.90/diluted; raises full-year guidance
Net income $0.20/diluted share; normalized FFO $0.90/diluted share.
Welltower Q1 normalized FFO $0.85; SHO SSNOI +23.4%; guides FY normalized FFO $3.39-$3.54
Net income $0.05 diluted EPS; normalized FFO $0.85 diluted.
Welltower Q4 normalized FFO $0.83 vs net loss $0.01; guides 2023 FFO $3.35-$3.53
Net loss attributable to common stockholders of $0.01 per diluted share; normalized FFO of $0.83 per diluted share in Q4 2022.
Welltower reports Q3 normalized FFO $0.84, up 5%; authorizes $3B buyback
Net loss of $0.01 per diluted share; normalized FFO of $0.84 per share, up 5.0% YoY.
Welltower Q2 normalized FFO $0.86 (+8.9% YoY); same-store NOI +8.7%
Net income $0.20/diluted share; normalized FFO $0.86, +8.9% YoY.
Welltower files $3B ATM equity program and registers 1.1M shares for DownREIT units
Entered Equity Distribution Agreement for up to $3B of common stock via ATM offering through multiple agents.
Mr. McHugh, age 40, was appointed Co-President & Chief Financial Officer after previously serving as Executive Vice President – Chief Financial Officer.
Mr. Chaudhri, age 37, was appointed Co-President & Chief Investment Officer after previously serving as Executive Vice President – Chief Investment Officer ("CIO").
On July 29, 2024 , the Board of Directors (the “Board”) of Welltower Inc. elected Andrew Gundlach to the Board to fill the vacancy created by the departure of Philip Hawkins, as disclosed on March 25, 2024.
On March 21, 2024, Philip Hawkins informed the Board of Directors (the “Board”) of Welltower Inc. (the “Company”) that he has decided to retire from the Board and will not stand for election at the 2024 Annual Meeting of Shareholders of the Company.
Effective December 28, 2023, Ayesha Menon, Executive Vice President, Wellness Housing and Development of Welltower Inc. (the “Company”), resigned her position as an officer of the Company.
Max materiality 1.00 · Median 0.62 · Most common event other_material